Hosted on MSN26d
Boral Capital sets $22 target on Scilex shares, rating BuyThe standout in Scilex's pipeline, according to Boral Capital, is SEMDEXA, a clinical-stage dexamethasone gel that has shown positive results in Phase 3 trials for sciatica. The analyst firm views ...
The primary corticosteroid used to control cerebral edema is dexamethasone. More than 40 years ago, dexamethasone was used in patients with brain tumors, and it is still used today. Other steroids ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results